JPMorgan Chase & Co’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $113 | Hold |
|
|||||
|
2025
Q2 | $63 | Sell |
|
|||||
|
2025
Q1 | $39.1K | Sell |
|
|||||
|
2024
Q4 | $337K | Buy |
|
|||||
|
2024
Q3 | $51.2K | Buy |
|
|||||
|
2024
Q2 | $43.1K | Buy |
|
|||||
|
2024
Q1 | $71.1K | Sell |
|
|||||
|
2023
Q4 | $66.9K | Hold |
|
|||||
|
2023
Q3 | $87K | Sell |
|
|||||
|
2023
Q2 | $185K | Sell |
|
|||||
|
2023
Q1 | $545K | Buy |
|
|||||
|
2022
Q4 | $119K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $0 | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $308K | Buy |
|
|||||
|
2021
Q1 | $396K | Buy |
|
|||||
|
2020
Q4 | $252K | Buy |
|
|||||
|
2020
Q3 | $58K | Sell |
|
|||||
|
2020
Q2 | $155K | Buy |
|
|||||
|
2020
Q1 | $38K | Sell |
|
|||||
|
2019
Q4 | $42K | Hold |
|
|||||
|
2019
Q3 | $49K | Buy |
|
|||||
|
2019
Q2 | $30K | Buy |
|
|||||
|
2019
Q1 | $4K | Sell |
|
|||||
|
2018
Q4 | $4K | Buy |
|
|||||
|
2018
Q3 | $2K | Sell |
|
|||||
|
2018
Q2 | $263K | Sell |
|
|||||
|
2018
Q1 | $5.66M | Buy |
|
|||||
|
2017
Q4 | $2.97M | Buy |
|